New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
EssilorLuxottica S.A.
ESLOY
Shape
US Flag

OTC

147B

Medical - Instruments & Supplies

Next Earning date - N/A

160.99USD

Shape4.34 ( 2.77%)
moonAfter-hours 161.20$arrow-right-up0.21 (0.13%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-94%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

0%

Quote Panel

Shape
Updated September 16, 2025
1W 3.80 % 1M 2.67 % 3M 14.12 % 1Y 42.93 %

Key Metrics

Shape
  • Market Cap

    146.83B


  • Shares Outstanding

    912.02M


  • Share in Float

    293.63M


  • Dividende

    2.24982


  • Earning Date

    No Data


  • Price Target

    160.99


  • Average Volume

    59004.1


  • Beta

    0.748


  • Range

    112.95-161.2


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.essilorluxottica.com


  • Sector

    Healthcare


Fundamentals

Shape

14.63x

P/E Ratio

4.58x

P/S Ratio

3.26x

P/B Ratio

0.4

Debt/Equity

8.7%

Net Margin

$3.0

EPS

How ESLOY compares to sector?

P/E Ratio

Relative Strength

Shape

ESLOY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$32B

Shape143%

2025-Revenue

$3.97

Shape265%

2025-EPS

$7B

Shape109%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

Barclays

initialise

Previous: Not converted

2025-09-09

Now: Overweight

UBS

upgrade

Previous: Not converted

2024-06-17

Now: Buy

HSBC

downgrade

Previous: Not converted

2024-04-09

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

NA
vs NA

Q4.22

arrow
arrow

+53%

2.36
vs 1.54

Q1.23

arrow
arrow

N/A

NA
vs NA

Q2.23

arrow
arrow

+19%

3.31
vs 2.77

Q3.23

arrow
arrow

N/A

NA
vs NA

Q4.23

arrow
arrow

-5%

2.25
vs 2.36

Q1.24

arrow
arrow

N/A

NA
vs NA

Q2.24

arrow
arrow

-3%

3.2
vs 3.31

Q3.24

arrow
arrow

N/A

NA
vs NA

Q4.24

arrow
arrow

0%

2.24
vs 2.25

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

+7%

12.9B  vs 12B

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

+0%

12.5B  vs 12.5B

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

+3%

13.3B  vs 12.9B

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

+5%

13.2B  vs 12.5B

Q1.25

arrow
arrow

NA

6.3B  vs NA

Q2.25

arrow
arrow

-54%

6.1B  vs 13.3B

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

NA

NA
vs NA

Q2.23

arrow
arrow

+4%

0.04
vs 0.03

Q3.23

arrow
arrow

NA

NA
vs NA

Q4.23

arrow
arrow

+2%

0.02
vs 0.04

Q1.24

arrow
arrow

NA

NA
vs NA

Q2.24

arrow
arrow

+3%

0.03
vs 0.02

Q3.24

arrow
arrow

NA

NA
vs NA

Q4.24

arrow
arrow

+2%

0.02
vs 0.03

Q1.25

arrow
arrow

NA

NA
vs NA

Q2.25

arrow
arrow

+4%

0.04
vs 0.02

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

11

11
vs 9

22%

Q2.23

arrow
arrow

13

13
vs 11

18%

Q3.23

arrow
arrow

10

10
vs 13

-23%

Q4.23

arrow
arrow

10

10
vs 10

NA

Q1.24

arrow
arrow

11

11
vs 10

10%

Q2.24

arrow
arrow

8

8
vs 11

-27%

Q3.24

arrow
arrow

6

6
vs 8

-25%

Q4.24

arrow
arrow

7

7
vs 6

17%

Q1.25

arrow
arrow

11

11
vs 7

57%

Q2.25

arrow
arrow

13

13
vs 11

18%

Earnings Growth

Latest News